We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $722M
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$2.32B
AUM Growth
+$39.2M
Cap. Flow
-$79.2M
Cap. Flow %
-3.41%
Top 10 Hldgs %
21.95%
Holding
363
New
104
Increased
55
Reduced
73
Closed
105

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$29.1M
2
ALL icon
Allstate
ALL
+$25M
3
HAL icon
Halliburton
HAL
+$24.6M
4
ELV icon
Elevance Health
ELV
+$24.2M
5
SNDK
SANDISK CORP
SNDK
+$22.2M

Sector Composition

Rank Sector Weight
1 Healthcare 15.94%
2 Communication Services 14.76%
3 Consumer Discretionary 12.85%
4 Technology 10.33%
5 Financials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNCN
126
DELISTED
BNC Bancorp
BNCN
$3.16M 0.14%
183,574
-3,800
-2% -$64.1K
SHPG
127
DELISTED
Shire pic
SHPG
$2.71M 0.12%
12,775
-44,587
-78% -$9.46M
CPRI icon
128
Capri Holdings
CPRI
$1.74B
$2.42M 0.1%
32,249
-451
-1% -$33.6K
C.WS.A
129
DELISTED
Citigroup Inc
C.WS.A
$2.35M 0.1%
2,700,985
PRA
130
DELISTED
ProAssurance
PRA
$2.26M 0.1%
+50,000
New +$2.29M
AIZ icon
131
Assurant
AIZ
$14.3B
$1.68M 0.07%
+24,500
New +$1.63M
BIIB icon
132
Biogen
BIIB
$30.7B
$1.66M 0.07%
4,900
-33,937
-87% -$11M
CLF icon
133
Cleveland-Cliffs
CLF
$6.99B
$1.51M 0.06%
+211,430
New +$1.84M
RVNC
134
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.41M 0.06%
83,000
-1,460
-2% -$25.5K
HTGC icon
135
Hercules Capital
HTGC
$3.23B
$1.38M 0.06%
92,976
IVR icon
136
Invesco Mortgage Capital
IVR
$805M
$1.19M 0.05%
7,726
-190
-2% -$30.7K
AR icon
137
Antero Resources
AR
$10.7B
$1.13M 0.05%
27,820
-300
-1% -$14.4K
AEGR
138
DELISTED
Aegerion Pharmaceuticals
AEGR
$980K 0.04%
46,791
-980
-2% -$24.7K
APO icon
139
Apollo Global Management
APO
$73.4B
$809K 0.03%
34,300
-128,387
-79% -$2.96M
ORCL icon
140
Oracle
ORCL
$423B
$562K 0.02%
12,500
TYC
141
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$536K 0.02%
11,680
+2,884
+33% +$128K
BR icon
142
Broadridge
BR
$19B
$522K 0.02%
11,300
+5,400
+92% +$236K
DTV
143
DELISTED
DIRECTV COM STK (DE)
DTV
$520K 0.02%
6,000
BBWI icon
144
Bath & Body Works
BBWI
$4.1B
$519K 0.02%
+7,422
New +$458K
GEN icon
145
Gen Digital
GEN
$17.5B
$518K 0.02%
+20,200
New +$502K
PRE
146
DELISTED
PARTNERRE LTD
PRE
$514K 0.02%
4,500
+2,200
+96% +$251K
KDP icon
147
Keurig Dr Pepper
KDP
$40.8B
$509K 0.02%
7,100
+3,000
+73% +$208K
FDS icon
148
Factset
FDS
$10.2B
$507K 0.02%
3,600
+1,500
+71% +$199K
COF icon
149
Capital One
COF
$134B
$504K 0.02%
6,100
+3,000
+97% +$244K
SWY
150
DELISTED
SAFEWAY INC
SWY
$502K 0.02%
14,300
+7,200
+101% +$249K

Similar funds

Zweig-DiMenna Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Zweig-DiMenna Associates held 363 positions worth $2.32B, up 1.7% from $2.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Zweig-DiMenna Associates withdrew a net $79.2M in Q4 2014, closing 105 positions and reducing 73 holdings. Its most notable exit was EMC CORPORATION, an estimated $29.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Zweig-DiMenna Associates opened a new position in Baker Hughes worth $46.3M.

  • Zweig-DiMenna Associates's largest Q4 2014 buy was Baker Hughes: 826,470 shares worth $46.3M.
  • Zweig-DiMenna Associates added most to Time Warner Inc in Q4 2014, an estimated $34.7M increase.
  • Zweig-DiMenna Associates's biggest Q4 2014 reduction was Allstate, cutting an estimated $25M.
  • Zweig-DiMenna Associates fully exited EMC CORPORATION in Q4 2014, selling an estimated $29.1M.
  • Zweig-DiMenna Associates's ten largest holdings make up 22% of its $2.32B portfolio in Q4 2014.
  • Zweig-DiMenna Associates opened 104 new positions and closed 105 in Q4 2014.
  • Zweig-DiMenna Associates's portfolio value rose 1.7% quarter-over-quarter to $2.32B.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2014, filed 12 Feb 2015.